SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-87007"
 

Search: onr:"swepub:oai:DiVA.org:liu-87007" > Anticancer drugs of...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Anticancer drugs of tomorrow : apoptotic pathways as targets for drug design

Los, Marek Jan (author)
Institute of Experimental Dermatology, University of Muenster, Germany
Burek, C. J. (author)
Institute of Experimental Dermatology, University of Muenster, Germany
Stroh, C. (author)
Institute of Experimental Dermatology, University of Muenster, Germany
show more...
Benedyk, K. (author)
Dept of Tumor Biology Oncology Center, Maria Sklodowska-Curie Memorial Institute, Wybrzeze Armii Krajowej 15, PL-44100 Gliwice, Poland
Hug, H. (author)
TheraSTrat AGGewerbestrasse 25, CH-4123, Allschwil, Switzerland
Mackiewicz, A. (author)
Dept of Cancer Immunology, University of Medical Sciences, at Great-Poland Cancer Center, Poznan, Poland
show less...
 (creator_code:org_t)
Elsevier, 2003
2003
English.
In: Drug Discovery Today. - : Elsevier. - 1359-6446 .- 1878-5832. ; 8:2, s. 67-77
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Apoptosis or programmed cell death is a set of ordered events that enables the selective removal of cells from tissue and is essential for homeostasis and proper function of multicellular organisms. Components of this signaling network, which include ligands, such as CD95, tumor necrosis factor (TNF) and TNF-related apoptosis-inducing ligand, as well as downstream molecules, such as caspases, Bcl-2 family members, and inhibitor-of-apoptosis proteins, which trigger and regulate apoptosis, are crucial targets for conventional drug development and gene therapy of cancer and other diseases. Here, we focus on apoptotic pathways and propose new potential molecular targets that could prove effective in controlling cell death in the clinical setting.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)

Keyword

bcl-2 protein family
caspase activation
cytochrome-c
interleukin-1-beta converting-enzyme
leukemia-cells
mice deficient
programmed cell-death
serine-protease
structural basis
trail-induced apoptosis

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Los, Marek Jan
Burek, C. J.
Stroh, C.
Benedyk, K.
Hug, H.
Mackiewicz, A.
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cancer and Oncol ...
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Medical Biotechn ...
and Medical Biotechn ...
Articles in the publication
Drug Discovery T ...
By the university
Linköping University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view